[Therapy monitoring of regional chemotherapy by magnetic resonance spectroscopy].
Semmler
W
W
Bachert-Baumann
P
P
Schlag
P
P
Gückel
F
F
Lorenz
W J
WJ
Van Kaick
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D002945:Cisplatin / Q000008:administration & dosage; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D010710:Phosphates; D010725:Phosphocreatine; D002945:Cisplatin; D008558:Melphalan
Therapieüberwachung regionaler Chemotherapie durch MR-Spektroskopie.